Source:http://linkedlifedata.com/resource/pubmed/id/15682292
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-4
|
pubmed:abstractText |
Substantial evidence suggests that a low folate/high homocysteine phenotype is pathogenic. We analyzed the impact of the thymidylate synthase (TYMS) 3'UTR ins/del polymorphism on folate and homocysteine levels and assessed the relationship between the TYMS 3'UTR ins/del polymorphism and key genetic and lifestyle variables. Among non-smokers only, the TYMS 3'UTR ins/del polymorphism was significantly associated with red blood cell folate (RBC folate; P=0.002) and homocysteine (P=0.03) concentrations. Median RBC folate concentration was much higher for TYMS 3'UTR del/del subjects (434 microg/l) compared with either ins/ins (282 microg/l) or ins/del (298 microg/l) subjects. The median homocysteine concentration for del/del homozygotes was considerably lower compared with either ins/ins homozygotes or ins/del heterozygotes. A possible additive effect for the impact of the TYMS 3'UTR del/del and MTHFR 677CC genotypes on RBC folate concentration was also observed. Our findings suggest that the TYMS 3'UTR del/del genotype is a significant determinant of elevated RBC folate concentration in a non-smoking population of northwestern European adults and that this genotype confers protection against diseases for which a low folate/high homocysteine phenotype appears to be an etiologic component.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0340-6717
|
pubmed:author |
pubmed-author:BorehamColin ACA,
pubmed-author:BrownKaren SKS,
pubmed-author:KealeyCarmelC,
pubmed-author:McNultyHeleneH,
pubmed-author:McPartlinJosephJ,
pubmed-author:MurrayLiamL,
pubmed-author:ScottJohn MJM,
pubmed-author:StrainJ JJJ,
pubmed-author:WhiteheadAlexander SAS,
pubmed-author:WoodsideJayne VJV,
pubmed-author:YoungIanI
|
pubmed:issnType |
Print
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
347-53
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15682292-3' Untranslated Regions,
pubmed-meshheading:15682292-Adult,
pubmed-meshheading:15682292-Erythrocytes,
pubmed-meshheading:15682292-Female,
pubmed-meshheading:15682292-Folic Acid,
pubmed-meshheading:15682292-Genotype,
pubmed-meshheading:15682292-Homocysteine,
pubmed-meshheading:15682292-Humans,
pubmed-meshheading:15682292-Male,
pubmed-meshheading:15682292-Polymorphism, Genetic,
pubmed-meshheading:15682292-Smoking,
pubmed-meshheading:15682292-Thymidylate Synthase
|
pubmed:year |
2005
|
pubmed:articleTitle |
A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations.
|
pubmed:affiliation |
Department of Pharmacology, University of Pennsylvania School of Medicine, 153 Johnson Pavilion, 3620 Hamilton Walk, Philadelphia, PA 19104-6084, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|